Helios Clinical Research, LLC.

Middleburg Heights, Ohio 44130

1 studies enrolling now · 5 studies all time

What they study most

Castration-Resistant Prostatic Cancer, Metastatic Castrate-sensitive Prostate Cancer, Metastatic Castration Resistant Prostate Cancer, Metastatic Castration-Resistant Prostate Cancer, Metastatic Castration-Sensitive Prostate Cancer, Metastatic Castration-sensitive Prostate Cancer, Non-Metastatic Castration-Resistant Prostate Cancer, Non-Muscle Invasive Bladder Neoplasms, Prostate Cancer

Studies at this site

• A Study to Evaluate TAR-210 Versus Intravesical Chemotherapy Treatment in Participants With High Risk Non-Muscle-Invasive Bladder Cancer — Recruiting now
• A Safety and Dose-finding Study of PRL-02 Depot in Men With Advanced Prostate Cancer — Recruiting now
• A Study of Niraparib in Combination With Abiraterone Acetate and Prednisone Versus Abiraterone Acetate and Prednisone for Treatment of Participants With Metastatic Prostate Cancer — Running, not enrolling
• A Study of an Intermittent ADT Approach With Apalutamide Monotherapy in Participants With mCSPC — Running, not enrolling
• Study of Relugolix in Men With Metastatic Castration-Sensitive Prostate Cancer or Non-Metastatic or Metastatic Castration-Resistant Prostate Cancer — Completed